Control and eliminate the most prevalent neglected diseases among the world's poorest and most vulnerable people.
The END Fund manages grants, provides technical assistance, and raises funding for controlling and eliminating neglected tropical diseases (NTDs). GiveWell has only reviewed the programs that treat schistosomiasis and soil-transmitted helminthiasis (STH) ("deworming"); their recommendation is just for this part of the END Fund's work.
Where they work:
Angola | Burundi | Côte D'lvoire | Democratic Republic of Congo | Ethiopia | Kenya | Liberia | Mali | Namibia | Niger | Nigeria | Rwanda | Tanzania | Zambia | Zimbabwe
Yemen | India
What do they do?
The END Fund, in collaboration with government partners and non-governmental organizations on the ground, treats NTDs by following a proven implementation model that is tailored to meet the needs of individual countries.
Successful implementation involves understanding the scale of the problem and designing a robust MDA campaign targeted to reach and treat the right people.
It is a process that catalyzes resources, builds capacity among health professionals, and mobilizes communities to distribute medicines for maximum impact at minimal cost.
Strategy on the Ground:
- Drug administration program.
- Financing mechanism to pool and leverage funds to invest in NTD programs across partners.
- Mission is to control & eliminate the most prevalent neglected diseases.
- - Mobilize and direct significant resources for NTDs to where they can have maximum impact.
- - Advocate for innovative, integrated and cost-effective NTD programs; and
- - Facilitate private sector engagement in the movement to address the devastating effects of NTDs.
- Pharmaceutical companies - donating meds.
- Ministries of Health.
- a large number of local and international implementing partners, government and academic partners.
- Sponsors: corporations, foundations, individuals
Why are they recommended?
END Fund is recommended by GiveWell.
- Since its founding, the END Fund has mobilized over USD75 million to treat people at risk of NTDs.
See more "fast facts": www.end.org/whoweare